WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Daniela Brünnert
PeerJ Editor, Author & Reviewer
590 Points

Contributions by role
Reviewer 90
Editor 500

Contributions by subject area
Cell Biology
Gastroenterology and Hepatology
Molecular Biology
Agricultural Science
Biochemistry
Biotechnology
Genetics
Genomics
Hematology
Oncology
Immunology
Respiratory Medicine
Gynecology and Obstetrics
Women's Health
Medical Genetics
Virology
Bioinformatics

Daniela Brünnert

PeerJ Editor, Author & Reviewer

Summary

My current research is related to autoimmune diseases, where we develop and express and characterize specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, I am interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest is related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.

Cell Biology Gastroenterology Gastroenterology & Hepatology Gynecology & Obstetrics Hepatology Molecular Biology Obstetrics & Gynecology Oncology Translational Medicine Urology

Editorial Board Member

PeerJ - the multidisciplinary STM open access journal

Work details

Senior Scientist

Universitätsklinikum Würzburg
March 2021
Experimental Tumor Immunology, Department of Obstetrics and Gynecology
My current research is related to autoimmune diseases, where we develop and express and characterize specific AIM biologicals as tools against diseases like Type 1 diabetes, Multiple Sclerosis, NMO, and Parkinson's disease. Apart from that, I am interested in the development of novel cancer therapies with a particular focus on Multiple Myeloma, but also investigating other solid tumors. And a last major interest in related to pregnancy and understanding more about the role of Thrombin in terms of cytokine regulation and its functional consequences for trophoblast cells.

Research Scientist, Post-Doc

University Hospital of Würzburg
July 2014
Comprehensive Cancer Center Mainfranken

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 3

Academic Editor on

April 15, 2022
miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos
Shuyuan Wu, Zhaofu Wu, Huiling Xu, Jinli Zhang, Wenyi Gu, Xiaohua Tan, Zemin Pan, Dongdong Cao, Dongmei Li, Lei Yang, Dongmei Li, Yuanming Pan
https://doi.org/10.7717/peerj.13233 PubMed 35444864
February 3, 2022
Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation
Tianying Zheng, Wenfei Han, Aijun Wang, Yonggang Wang
https://doi.org/10.7717/peerj.12802 PubMed 35186455
October 15, 2021
The role of zinc transporter proteins as predictive and prognostic biomarkers of hepatocellular cancer
Ceylan V. Bitirim
https://doi.org/10.7717/peerj.12314 PubMed 34721988